LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients

NCT04391595 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma
GBM
Glioma

Interventions

DRUG: Abemaciclib
DRUG: LY3214996

Sponsor

Nader Sanai

Collaborators

[object Object]
[object Object]
[object Object]